Clorgyline and deprenyl attenuate striatal malonate and 3- nitropropionic acid lesions

Brain Research

Volumn 834, Issue 1-2, 1999, Pages 168-172

  Maragos, William F ^a   Tillman, Philip A ^a   Chesnut, M Dathan ^a   Jakel, Rebekah J ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Dopamine; Excitotoxicity; Mitochondria; Monoamine oxidase; Reactive oxygen species; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; CLORGYLINE; DOPAMINE; MALONIC ACID; MONOAMINE OXIDASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SELEGILINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; DOPAMINE METABOLISM; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CLORGYLINE; CORPUS STRIATUM; ELECTRON TRANSPORT COMPLEX II; MALE; MALONATES; MITOCHONDRIA; MONOAMINE OXIDASE INHIBITORS; MULTIENZYME COMPLEXES; NEUROTOXINS; NITRO COMPOUNDS; OXIDOREDUCTASES; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SELEGILINE; SUCCINATE DEHYDROGENASE;

EID: 0033542783     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01487-0     Document Type: Article

References (29)

1. Almeida A., Heales S.J.R., Bolaños J.P., Medina J.M. Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. 790:1998;209-216.
2. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storey E., Srivastava R., Rosen B.R., Hyman B.T. Neurochemical and histological characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13:1993;4181-4192.
3. Beal M.F., Brouillet E., Jenkins B., Henshaw R., Rosen B., Hyman B.T. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61:1993;1147-1150.
4. Blunt S.B., Jenner P., Marsden C.D. Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine. Mov. Disord. 8:1993;129-133.
5. Brouillet E., Jenkins B.G., Hyman B.T., Ferrante R.J., Kowall N.W., Srivastava R., Roy D.S., Rosen B.R., Beal M.F. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60:1993;356-359.
6. Brouillet E., Hantraye P., Ferrante R.J., Dolan R., Leroy-Willig A., Kowall N.W., Beal M.F. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7105-7109.
7. Brouillet E., Guyot M.C., Miltoux V., Altairac S., Conde F., Palfi S., Hantraye P. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J. Neurochem. 70:1998;794-805.
8. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M.K., Bird E.D., Beal M.F. Oxidative damage and metabolic dysfunction in HD: selective vulnerability of the basal ganglia. Ann. Neurol. 41:1997;646-653.
9. Buisson A., Pateau V., Plotkine M., Boulu R.G. Nigrostriatal pathway modulates striatum vulnerability to quinolinic acid. Neurosci. Lett. 131:1991;257-259.
10. Carrillo M.C., Kitani K., Kanai S., Sato Y., Ivy G.O., Miyasaka K. Long-term treatment with (-) deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain. Life Sci. 59:1996;1047-1057.
11. Chapman A.G., Dürmuller N., Lee G.J., Meldrum B.S. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibers. Neurosci. Lett. 107:1989;256-260.
12. Cohen G., Spina M.B. Deprenyl suppresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26:1989;689-690.
13. Dugan L.L., Sensi S.L., Canzoniero L.M.T., Handran S.D., Rothman S.M., Lin T.S., Goldberg M.P., Choi D.W. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15:1995;6377-6388.
14. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 230:1985;561-563.
15. Filloux F., Wamsley J.K. Dopaminergic modulation of excitotoxicity in rat striatum: evidence from nigrostriatal lesions. Synapse. 8:1991;281-288.
16. Garrett M.C., Soares-Da Silva P. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat. Neuropharmacology. 29:1990;875-879.
17. Globus M.Y.T., Busto R., Dietrich W.D., Scheinberg P., Ginsberg M.D. Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci. Lett. 80:1987;251-256.
18. Greene J.G., Porter R.H.P., Eller R.V., Greenamyre J.T. Inhibition of succinate dehydrogenase by malonic acid produces an excitotoxic lesion in rat striatum. J. Neurochem. 61:1993;1151-1154.
19. Hastings T.G., Lewis D.A., Zigmond M.L. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1956-1961.
20. Hoyt K.R., Reynolds I.J., Hastings T.G. Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death. Exp. Neurol. 143:1997;269-281.
21. Kageyama G.H., Wong-Riley M.T.T. Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specific neuronal types and afferent pathways. Neuroscience. 7:1982;2337-2361.
22. Kindt M.V., Youngster S.K., Sonsalla P.K., Duvoisin R.C., Heikkila R.E. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2′ Me-MPTP. Eur. J. Pharmacol. 146:1988;313-318.
23. Maragos W.F., Penney J.B., Young A.B. Anatomical correlation of NMDA and TCP receptors in rat brain. J. Neurosci. 8:1988;493-501.
24. Maragos W.F., Jakel R.J., Pang Z., Geddes J.W. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions. Exp. Neurol. 154:1998;637-644.
25. Maruyama W., Takahashi T., Naoi M. (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide. J. Neurochem. 70:1998;2510-2515.
26. McLaughlin B.A., Nelson D., Erecinska M., Chesselet M.-F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem. 70:1998;2406-2415.
27. Reynolds D.S., Carter R.J., Morton A.J. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J. Neurosci. 18:1998;10116-10127.
28. Rosenberg P.A. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 8:1988;2887-2894.
29. Smith T.S., Parker W.D., Bennett J.P. L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity. NeuroReport. 5:1994;1009-1011.